A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER-2 Positive Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: IV LBH589|DRUG: Oral LBH589|DRUG: trastuzumab|DRUG: paclitaxel
Sponsor: Novartis Pharmaceuticals